RxDoctor Payments Data

Amber Adams

Primary Care · Marianna, FLNPI 1255980736

Payments from drug & device makers

$310in general payments, 2019–2025

Across 13 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alpha Cognition USA, Inc.$96
  • Otsuka America Pharmaceutical, Inc.$68
  • Lilly USA, LLC$40
  • Teva Pharmaceuticals USA, Inc.$38
  • Avanir Pharmaceuticals, Inc.$30
  • AstraZeneca$20
  • plus $18 from 1 others

What the payments were for

  • Food & beverage$310100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$310 in reported general payments places this provider in the 45th percentile of 725 primary care providers in Florida.

See all primary care providers in Florida

Medicare billing

Part B allowed, 2024
$259,746
Medicare patients
363
Services billed
3,171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine32$94,368
EliquisApixaban189$64,591
TrulicityDulaglutide50$28,641
OzempicSemaglutide23$23,487
EntrestoSacubitril/Valsartan68$23,439
LinzessLinaclotide19$10,547
ErtapenemErtapenem Sodium23$10,487
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog126$10,415
Combivent RespimatIpratropium/Albuterol Sulfate19$10,358
XareltoRivaroxaban35$10,125
SantylCollagenase Clostridium Hist.21$9,301
JardianceEmpagliflozin25$9,054
Tresiba Flextouch U-100Insulin Degludec58$8,021
Potassium Chloride177$7,282
Atorvastatin Calcium400$6,292

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$38$94,36832 claims
Lilly USA, LLCTrulicity$40$28,64150 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 725 primary care providers in Florida.

Other primary care in Marianna

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →